Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Interim findings from ongoing phase I trial of OncoVEX(GM-CSF)

June 6, 2003

HER-2/neu vaccine enters phase I trial for breast cancer

June 6, 2003

Oncofetal protein validated as a potential target for lung cancer immunotherapy

June 6, 2003

EMD-72000 shows good tolerability and evidence of antitumor activity in phase I trials

June 5, 2003

Orphan drug status awarded to KSB-303 for pancreatic cancer

May 30, 2003

Safety phase of lactoferrin study completed

May 27, 2003

TroVax trial in renal cancer cleared to begin

May 22, 2003

Preliminary phase II Onyvax-P results

May 19, 2003

Evidence of cytotoxic effects of IL-13-PE38QQR in brain cancer

May 19, 2003

Second Merck antibody advances to phase II trials

May 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...